Faculty Opinions recommendation of JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients.

2013 ◽  
Author(s):  
Philip Rosenthal
Keyword(s):  
Randomized Trial ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Pegylated Interferon Alpha ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1

JUMP-C: A randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients

Hepatology ◽  
2013 ◽  
Vol 58 (2) ◽  
pp. 514-523 ◽  
Author(s):  
Paul J. Pockros ◽  
Donald Jensen ◽  
Naoky Tsai ◽  
Ryan Taylor ◽  
Alnoor Ramji ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Pegylated Interferon Alpha ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1

scholarly journals Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials

2016 ◽  
Vol 15 (3) ◽  
pp. 333-349 ◽  
Author(s):  
Donald M. Jensen ◽  
Tarik Asselah ◽  
Douglas Dieterich ◽  
Graham R. Foster ◽  
Mark S. Sulkowski ◽  
...  
Keyword(s):  
Pegylated Interferon ◽  
Pooled Analysis ◽  
Genotype 1 ◽  
Phase 3 ◽  
Two Phase ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1
Sign in / Sign up

Export Citation Format

Share Document